Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

被引：0
|
作者：
Xing-dong Xu
Lan Yang
Li-yun Zheng
Yan-yan Pan
Zhi-fei Cao
Zhi-qing Zhang
Quan-sheng Zhou
Bo Yang
Cong Cao
机构：
[1] the Third Hospital affiliated to Soochow University,Department of General Surgery
[2] the First Affiliated Hospital of Soochow University,Department of Neurology
[3] Cyrus Tang Hematology Center,undefined
[4] Soochow University,undefined
[5] Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Institute of Neuroscience,undefined
[6] Soochow University,undefined
来源：
BMC Cancer | / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells
    Xing-dong Xu
    Lan Yang
    Li-yun Zheng
    Yan-yan Pan
    Zhi-fei Cao
    Zhi-qing Zhang
    Quan-sheng Zhou
    Bo Yang
    Cong Cao
    BMC Cancer, 14
  • [2] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells
    Xu, Xing-dong
    Yang, Lan
    Zheng, Li-yun
    Pan, Yan-yan
    Cao, Zhi-fei
    Zhang, Zhi-qing
    Zhou, Quan-sheng
    Yang, Bo
    Cao, Cong
    BMC CANCER, 2014, 14
  • [3] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells (vol 14, 373, 2014)
    Xu, Xing-dong
    Yang, Lan
    Zheng, Li-yun
    Pan, Yan-yan
    Cao, Zhi-fei
    Zhang, Zhi-qing
    Zhou, Quan-sheng
    Yang, Bo
    Cao, Cong
    BMC CANCER, 2016, 16
  • [4] The mechanism of Histone deacetylase inhibitor (Suberoylanilide hydroxamic acid) suppresses pancreatic cancer in vitro
    Yang, Bo
    Li, Shengze
    Zhou, Quansheng
    Cao, Cong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S44 - S44
  • [5] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Butler, LM
    Agus, DB
    Scher, HI
    Higgins, B
    Rose, A
    Cordon-Cardo, C
    Thaler, HT
    Rifkind, RA
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2000, 60 (18) : 5165 - 5170
  • [6] Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
    Kumagai, Takashi
    Wakimoto, Naoki
    Yin, Dong
    Gery, Sigal
    Kawamata, Norihiko
    Takai, Noriyuki
    Komatsu, Naoki
    Chumakov, Alexy
    Imai, Yasufumi
    Koeffler, H. Phillip
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 656 - 665
  • [7] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
    Munster, PN
    Troso-Sandoval, T
    Rosen, N
    Rifkind, R
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2001, 61 (23) : 8492 - 8497
  • [8] Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication
    Saha, Bratati
    Parks, Robin J.
    JOURNAL OF VIROLOGY, 2019, 93 (12)
  • [9] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Induces Differentiation of Intestinal Cells
    Roostaee, Alireza
    Benoit, Yannick D.
    Guezguez, Amel
    Simoneau, Aline
    Beaulieu, Jean-Francois
    GASTROENTEROLOGY, 2014, 146 (05) : S785 - S785
  • [10] Histone deacetylase inhibitor suberoylanilide hydroxamic acid targets breast cancer stem cells and inhibits metastasis
    Chu, K.
    Green, T. L.
    Boley, K. M.
    Cristofanilli, M.
    Robertson, F. M.
    CANCER RESEARCH, 2013, 73
12345